Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Association of Pharmacists Belgium, Brussels, Belgium.
BMC Health Serv Res. 2023 Jun 29;23(1):709. doi: 10.1186/s12913-023-09704-0.
Self-testing has been promoted as a means of increasing COVID-19 test coverage. In Belgium, self-testing was recommended as a complement to the formal, provider-administered indications, such as out of courtesy before meeting others and when feared to be infected. More than a year after the introduction of self-testing their place in the test strategy was evaluated.
We assessed trends in the number of self-tests sold, the number of positive self-tests reported, the proportion sold self-tests/total tests, and the proportion of all positive tests that were confirmed self-tests. To evaluate the reason why people use self-tests, we used the results of two online surveys among members of the general population: one among 27,397 people, held in April 2021, and one among 22,354 people, held in December 2021.
The use of self-tests became substantial from end 2021 onwards. In the period mid-November 2021 - end-of-June 2022, the average proportion of reported sold self-tests to all COVID-19 tests was 37% and 14% of all positive tests were positive self-tests. In both surveys, the main reported reasons for using a self-test were having symptoms (34% of users in April 2021 and 31% in December 2021) and after a risk contact (27% in both April and December). Moreover, the number of self-tests sold, and the number of positive self-tests reported closely followed the same trend as the provider-administered tests in symptomatic people and high risk-contacts, which reinforces the hypothesis that they were mainly used for these two indications.
From end 2021 onwards, self-testing covered a significant part of COVID-19 testing in Belgium, which increased without doubt the testing coverage. However, the available data seem to indicate that self-testing was mostly used for indications outside of official recommendations. If and how this affected the control of the epidemic remains unknown.
自我检测已被推广为增加 COVID-19 检测覆盖率的一种手段。在比利时,自我检测被推荐作为正式的、由提供者管理的检测的补充,例如出于礼貌在与他人见面之前,或者担心自己被感染时。自我检测推出一年多后,对其在检测策略中的地位进行了评估。
我们评估了销售的自我检测数量、报告的阳性自我检测数量、销售的自我检测数量/总检测数量的比例,以及所有阳性检测中确认的自我检测数量的比例。为了评估人们使用自我检测的原因,我们使用了两项针对普通人群成员的在线调查结果:一项调查于 2021 年 4 月进行,共有 27397 人参与,另一项调查于 2021 年 12 月进行,共有 22354 人参与。
从 2021 年底开始,自我检测的使用量大幅增加。在 2021 年 11 月中旬至 2022 年 6 月底期间,报告的销售的自我检测数量占所有 COVID-19 检测的平均比例为 37%,所有阳性检测中 14%为阳性自我检测。在这两项调查中,使用自我检测的主要报告原因是出现症状(2021 年 4 月有 34%的使用者,2021 年 12 月有 31%)和有风险接触(2021 年 4 月和 12 月均有 27%)。此外,销售的自我检测数量和报告的阳性自我检测数量与有症状的人和高风险接触者的提供者管理检测数量密切相关,这进一步证实了自我检测主要用于这两种检测的假设。
从 2021 年底开始,自我检测覆盖了比利时 COVID-19 检测的很大一部分,无疑增加了检测的覆盖范围。然而,现有数据似乎表明,自我检测主要用于官方建议之外的检测。这是否以及如何影响疫情的控制仍不得而知。